Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Arrhythmogenic right ventricular cardiomyopathy 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
2 Arrhythmogenic right ventricular cardiomyopathy 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
3 Arrhythmogenic right ventricular cardiomyopathy 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
4 Arrhythmogenic right ventricular cardiomyopathy 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
5 Arrhythmogenic right ventricular cardiomyopathy 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
6 Cell adhesion molecules 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
7 Cell adhesion molecules 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
8 Cell adhesion molecules 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
9 Cell adhesion molecules 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
10 Cell adhesion molecules 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
11 Cytoskeleton in muscle cells 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
12 Cytoskeleton in muscle cells 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
13 Cytoskeleton in muscle cells 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
14 Cytoskeleton in muscle cells 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
15 Cytoskeleton in muscle cells 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
16 Dilated cardiomyopathy 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
17 Dilated cardiomyopathy 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
18 Dilated cardiomyopathy 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
19 Dilated cardiomyopathy 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
20 Dilated cardiomyopathy 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
21 ECM-receptor interaction 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
22 ECM-receptor interaction 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
23 ECM-receptor interaction 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
24 ECM-receptor interaction 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
25 ECM-receptor interaction 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
26 Focal adhesion 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
27 Focal adhesion 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
28 Focal adhesion 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
29 Focal adhesion 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
30 Focal adhesion 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
31 Hematopoietic cell lineage 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
32 Hematopoietic cell lineage 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
33 Hematopoietic cell lineage 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
34 Hematopoietic cell lineage 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
35 Hematopoietic cell lineage 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
36 Human papillomavirus infection 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
37 Human papillomavirus infection 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
38 Human papillomavirus infection 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
39 Human papillomavirus infection 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
40 Human papillomavirus infection 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
41 Hypertrophic cardiomyopathy 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
42 Hypertrophic cardiomyopathy 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
43 Hypertrophic cardiomyopathy 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
44 Hypertrophic cardiomyopathy 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
45 Hypertrophic cardiomyopathy 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
46 Intestinal immune network for IgA production 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
47 Intestinal immune network for IgA production 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
48 Intestinal immune network for IgA production 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
49 Intestinal immune network for IgA production 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
50 Intestinal immune network for IgA production 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
51 Leishmaniasis 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
52 Leishmaniasis 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
53 Leishmaniasis 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
54 Leishmaniasis 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
55 Leishmaniasis 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
56 Leukocyte transendothelial migration 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
57 Leukocyte transendothelial migration 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
58 Leukocyte transendothelial migration 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
59 Leukocyte transendothelial migration 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
60 Leukocyte transendothelial migration 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
61 PI3K-Akt signaling pathway 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
62 PI3K-Akt signaling pathway 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
63 PI3K-Akt signaling pathway 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
64 PI3K-Akt signaling pathway 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
65 PI3K-Akt signaling pathway 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
66 Regulation of actin cytoskeleton 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
67 Regulation of actin cytoskeleton 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
68 Regulation of actin cytoskeleton 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
69 Regulation of actin cytoskeleton 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
70 Regulation of actin cytoskeleton 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬
71 Yersinia infection 💬
1件: ITGA4 💬 Abrilumab 💬 Abrilumab 2件: 96, 97 💬
72 Yersinia infection 💬
1件: ITGA4 💬 Carotegrast methyl 💬 Carotegrast methyl 1件: 97 💬
73 Yersinia infection 💬
1件: ITGA4 💬 Firategrast 💬 Firategrast 1件: 13 💬
74 Yersinia infection 💬
1件: ITGA4 💬 Natalizumab 💬 Natalizumab 5件: 13, 15, 25, 46, 96 💬
75 Yersinia infection 💬
1件: ITGA4 💬 Vedolizumab 💬 Vedolizumab 3件: 94, 96, 97 💬